Role of Alternative Donor Allogeneic Transplants in the Therapy of Acute Myeloid Leukemia

Restricted access

Adult acute myeloid leukemia (AML) is often associated with a poor prognosis, with allogeneic transplantation representing the greatest chance of cure for eligible patients. Historically, the preferred donor source is a human leukocyte antigen–matched blood relative, although only approximately 30% of patients have access to such a donor. Alternative donor sources, including matched unrelated donors, umbilical cord blood, and haploidentical related donors, are available for almost every patient and are increasingly being used for patients without a matched related donor. Survival outcomes with these alternative donor sources now approximate those of matched related donor transplants. Given the safety and success of alternative donor transplants, comparative trials are needed to reassess the optimal donor source for patients with AML. This review summarizes the available data on these alternative donor transplants. Further investigation is needed to contemporize donor selection algorithms, but, in the current era, donor availability should no longer preclude a patient's eligibility for an allogeneic blood or marrow transplant.

Correspondence: Keith W. Pratz, MD, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB 1 Room 2M45, Baltimore, MD 21287. E-mail: kpratz1@jhmi.edu
  • 1.

    DöhnerHEsteyEAmadoriS. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood2010;115:453.

    • Search Google Scholar
    • Export Citation
  • 2.

    YanadaMMatsuoKEmiNNaoeT. Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis. Cancer2005;103:16521658.

    • Search Google Scholar
    • Export Citation
  • 3.

    KorethJSchlenkRKopeckyK. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA2009;301:23492361.

    • Search Google Scholar
    • Export Citation
  • 4.

    BurnettAGoldstoneAHillsR. Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission. J Clin Oncol2013;31:12931301.

    • Search Google Scholar
    • Export Citation
  • 5.

    RashidiAEbadiMColditzGDiPersioJ. Outcomes of allogeneic stem cell transplantation in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis. Biol Blood Marrow Transplant2016;22:651657.

    • Search Google Scholar
    • Export Citation
  • 6.

    PrébetTGoreSDEsterniB. Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure. J Clin Oncol2011;29:33223327.

    • Search Google Scholar
    • Export Citation
  • 7.

    BurnettAWheatleyKGoldstoneA. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Hematol2002;118:385400.

    • Search Google Scholar
    • Export Citation
  • 8.

    DoresGDevesaSCurtisR. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood2012;119:3443.

    • Search Google Scholar
    • Export Citation
  • 9.

    DiaconescuRFlowersCStorerB. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood2004;104:15501558.

    • Search Google Scholar
    • Export Citation
  • 10.

    ChamplinRKhouriIAnderliniP. Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Nature2001;27(Suppl 2):S1322.

    • Search Google Scholar
    • Export Citation
  • 11.

    AnasettiCAmosDBeattyPG. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med1987;320:197204.

    • Search Google Scholar
    • Export Citation
  • 12.

    CliftRHansenJThomasE. Marrow transplantation from donors other than HLA-identical siblings. Transplantation1979;28:235242.

  • 13.

    BeattyPCliftRMickelsonE. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med1985;313:765771.

  • 14.

    EngHLeffellM. Histocompatibility testing after fifty years of transplantation. J Immunol Methods2011;369:121.

  • 15.

    BonnetDWarrenEGreenbergP. CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc Natl Acad Sci U S A1999;96:86398644.

    • Search Google Scholar
    • Export Citation
  • 16.

    GragerLEapenMWilliamsE. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med2014;371:339348.

  • 17.

    HorowitzMGaleRSondelP. Graft-versus-leukemia reactions after bone marrow transplantation. Blood1990;75:555562.

  • 18.

    GaleRHorowitzMAshR. Identical-twin bone marrow transplants for leukemia. Ann Intern Med1994;120:646652.

  • 19.

    SpellmanSEapenMLoganB. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood2012;120:259265.

    • Search Google Scholar
    • Export Citation
  • 20.

    BrayRHurleyCKamaniN. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant2008;14:4553.

    • Search Google Scholar
    • Export Citation
  • 21.

    LownRShawB. Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. Bone Marrow Transplant2013;48:210219.

    • Search Google Scholar
    • Export Citation
  • 22.

    SaberWOpieSRizzoJ. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood2012;119:39083916.

    • Search Google Scholar
    • Export Citation
  • 23.

    GuptaVTallmanMHeW. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood2010;116:18391848.

    • Search Google Scholar
    • Export Citation
  • 24.

    FrassoniFLabopinMPowlesR. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Lancet2000;355:13931398.

    • Search Google Scholar
    • Export Citation
  • 25.

    PageJOthusMGarcia-ManeroG. Feasibility of allogeneic hematopoietic cell transplantation among high-risk AML patients in first complete remission: results of the transplant objective from the SWOG (S1203) randomized phase III study of induction therapy using standard 7+3 therapy or idarubicin with high-dose cytarabine (IA) versus IA plus vorinostat [abstract]. Presented at the 58th ASH Annual Meeting & Exposition; December3–62016; San Diego, California. Abstract 1166.

    • Search Google Scholar
    • Export Citation
  • 26.

    LeeSKleinJHaagensonM. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood2007;110:45764583.

    • Search Google Scholar
    • Export Citation
  • 27.

    BroxmeyerHDouglasGHangocG. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A1989;86:38283832.

    • Search Google Scholar
    • Export Citation
  • 28.

    GluckmanEBroxmeyerHAuerbachA. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med1989;321:11741178.

    • Search Google Scholar
    • Export Citation
  • 29.

    KurtzbergJLaughlinMGrahamM. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med1996;355:157166.

    • Search Google Scholar
    • Export Citation
  • 30.

    BroxmeyerHLeeMHangocG. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood2011;117:47734777.

    • Search Google Scholar
    • Export Citation
  • 31.

    EapenMRubinsteinPZhangM. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet2007;369:19471954.

    • Search Google Scholar
    • Export Citation
  • 32.

    LaughlinMBarkerJBambachB. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med2001;344:18151822.

    • Search Google Scholar
    • Export Citation
  • 33.

    RochaVLabopinMSanzG. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med2004;351:22762285.

    • Search Google Scholar
    • Export Citation
  • 34.

    EapenMRochaVSanzG. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol2010;11:653660.

    • Search Google Scholar
    • Export Citation
  • 35.

    WagnerJBarkerJDeForT. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood2002;100:16111618.

    • Search Google Scholar
    • Export Citation
  • 36.

    BarkerJWeisdorfDDeForT. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood2005;105:13431347.

    • Search Google Scholar
    • Export Citation
  • 37.

    MichelGGalambrunCSirventA. Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome. Blood2016;127:34503457.

    • Search Google Scholar
    • Export Citation
  • 38.

    WagnerJEapenMCarterS. One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med2014;371:16851694.

  • 39.

    MilanoFGooleyTWoodB. Cord-blood transplantation in patients with minimal residual disease. N Engl J Med2016;375:944953.

  • 40.

    deLimaMMcNieceIRobinsonS. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med2012;367:23052315.

  • 41.

    BrunsteinCEapenMAhnK. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood2012;119:55915598.

    • Search Google Scholar
    • Export Citation
  • 42.

    ChaoNLiuCRooneyB. Nonmyeloablative regimen preserves “niches” allowing for peripheral expansion of donor T-cells. Biol Bone Marrow Tranplant2002;8:249256.

    • Search Google Scholar
    • Export Citation
  • 43.

    KanakryCFuchsELuznikL. Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat Rev Clin Oncol2016;13:1024.

  • 44.

    SzydloRGoldmanJKleinJ. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol1997;15:17671777.

    • Search Google Scholar
    • Export Citation
  • 45.

    ReisnerYKirkpatrickDDupontB. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet1981;318:327331.

    • Search Google Scholar
    • Export Citation
  • 46.

    AshRHorowitzMGaleR. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant1991;7:443452.

    • Search Google Scholar
    • Export Citation
  • 47.

    AversaFTabilioAVelardiA. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med1998;339:11861193.

    • Search Google Scholar
    • Export Citation
  • 48.

    AversaFTerenziATabilioA. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol2005;23:34473454.

    • Search Google Scholar
    • Export Citation
  • 49.

    BethgeWFaulCBornhäuserM. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Blood Cells Mol Dis2008;40:1319.

    • Search Google Scholar
    • Export Citation
  • 50.

    AiroldiIBertainaAPrigioneI. γδT-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+. Blood2015;125:23492358.

    • Search Google Scholar
    • Export Citation
  • 51.

    PerruccioKTostiABurchielliE. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood2005;106:43974406.

    • Search Google Scholar
    • Export Citation
  • 52.

    MartelliMDiIanniMRuggeriL. “Designed” grafts for HLA-haploidentical stem cell transplantation. Blood2014;123:967973.

  • 53.

    HuangXLiuDLiuK. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant2006;38:291297.

    • Search Google Scholar
    • Export Citation
  • 54.

    WangYLiuQXuL. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood2015;125:39563962.

    • Search Google Scholar
    • Export Citation
  • 55.

    LuznikLO'DonnellPSymonsH. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant2008;14:641650.

    • Search Google Scholar
    • Export Citation
  • 56.

    McCurdySKanakryJShowelM. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood2015;125:30243031.

    • Search Google Scholar
    • Export Citation
  • 57.

    Di StasiAMiltonDRPoonLM. Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and related Donors. Biol Blood Marrow Transplant2014;20:19751981.

    • Search Google Scholar
    • Export Citation
  • 58.

    KasamonYBolaños-MeadeJPrinceG. Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults. J Clin Oncol20015;33:31523161.

    • Search Google Scholar
    • Export Citation
  • 59.

    BrunsteinCFuchsECarterS. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood2011;118:282288.

    • Search Google Scholar
    • Export Citation
  • 60.

    CieriNGrecoRCrucittiL. Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells. Biol Blood Marrow Transplant2015;21:15061514.

    • Search Google Scholar
    • Export Citation
  • 61.

    CiureaSZhangMBacigalupoA. Haploidentical transplant with post-transplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia. Blood2015;126:10331040.

    • Search Google Scholar
    • Export Citation
  • 62.

    HeemskerkMvanWalravenSCornelissenJ. How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!Bone Marrow Transplant2005;35:645652.

    • Search Google Scholar
    • Export Citation
  • 63.

    BarkerJKrepskiTDeForT. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant2002;8:257.

    • Search Google Scholar
    • Export Citation
  • 64.

    GibsonCKennedyJNikiforowS. Donor chip causes donor-derived clonal hematopoiesis as an early complication of allogeneic stem cell transplantation [abstract]. Presented at the 58th ASH Annual Meeting & Exposition; December3–62016; San Diego, California. Abstract 987.

    • Search Google Scholar
    • Export Citation
  • 65.

    KrögerNZabelinaTdeWreedeL. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia2013;27:604609.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 188 165 20
PDF Downloads 50 44 6
EPUB Downloads 0 0 0